What Are The Possible Side Effects Of CAR T-Cell Immunotherapy?

January 14, 2021by admin
  • Cytopenia – Cytopenia occurs when one or more of the blood cell types are lower than it should be. Blood consists of red blood cells which carry oxygen and nutrients around the body, and white blood cells which fight infection.
  • B-Cell Aplasia – B-Cell aplasia occurs when anti-CD19 CAR T-Cells kill normal B lymphocytes that express CD19. These patients are typically at high risk of developing infections, because of their hypogammaglobulinemia. However, this can be treated with intravenous immunoglobulin (IVIG) replacement therapy.
  • Cytokine Release Syndrome (CRS) – Potentially life-threatening condition that results from the pathologic over-activation of T-Cells. It is an acute systemic inflammatory syndrome characterised by fever and multiple organ dysfunction.
  • Neurotoxicity – Damage to the brain or peripheral nervous system caused by exposure to natural or man-made toxic substances. These toxins can alter the activity of the nervous system in ways that can disrupt or kill nerves.
COMPANY

Sign up for you and your loved ones to receive the latest news and updates about CAR T-Cell Immunotherapy.

    https://immunotherapy.life/wp-content/uploads/2021/02/MGRC-LogoFooter.png
    https://immunotherapy.life/wp-content/uploads/2021/01/MGRC-Logo.png
    https://immunotherapy.life/wp-content/uploads/2021/02/Cyterium-Logo-RGB-02-320x68.png
    https://immunotherapy.life/wp-content/uploads/2021/01/MGRC-Logo.png

    Copyright © 2021 Malaysian Genomics Resource Centre Berhad (652790-V). All Rights Reserved.

    Copyright © 2021 Malaysian Genomics Resource Centre Berhad (652790-V). All Rights Reserved.